307 related articles for article (PubMed ID: 8383678)
1. Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events.
Secrist JP; Burns LA; Karnitz L; Koretzky GA; Abraham RT
J Biol Chem; 1993 Mar; 268(8):5886-93. PubMed ID: 8383678
[TBL] [Abstract][Full Text] [Related]
2. Induction of tyrosine phosphorylation and T-cell activation by vanadate peroxide, an inhibitor of protein tyrosine phosphatases.
Imbert V; Peyron JF; Farahi Far D; Mari B; Auberger P; Rossi B
Biochem J; 1994 Jan; 297 ( Pt 1)(Pt 1):163-73. PubMed ID: 7506531
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta abrogates TCR-mediated signaling by upregulating tyrosine phosphatases in T cells.
Choudhry MA; Sir O; Sayeed MM
Shock; 2001 Mar; 15(3):193-9. PubMed ID: 11236902
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of the T-cell antigen receptor-CD3 complex signaling pathway by the tyrosine phosphatase inhibitor pervanadate is mediated by inhibition of CD45: evidence for two interconnected Lck/Fyn- or zap-70-dependent signaling pathways.
Imbert V; Farahifar D; Auberger P; Mary D; Rossi B; Peyron JF
J Inflamm; 1996; 46(2):65-77. PubMed ID: 8734787
[TBL] [Abstract][Full Text] [Related]
5. Pervanadate simulates the effects of interleukin-2 (IL-2) in human T cells and provides evidence for the activation of two distinct tyrosine kinase pathways by IL-2.
Evans GA; Garcia GG; Erwin R; Howard OM; Farrar WL
J Biol Chem; 1994 Sep; 269(38):23407-12. PubMed ID: 8089104
[TBL] [Abstract][Full Text] [Related]
6. The CD45 tyrosine phosphatase regulates specific pools of antigen receptor-associated p59fyn and CD4-associated p56lck tyrosine in human T-cells.
Biffen M; McMichael-Phillips D; Larson T; Venkitaraman A; Alexander D
EMBO J; 1994 Apr; 13(8):1920-9. PubMed ID: 8168490
[TBL] [Abstract][Full Text] [Related]
7. Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor.
Cahir McFarland ED; Hurley TR; Pingel JT; Sefton BM; Shaw A; Thomas ML
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1402-6. PubMed ID: 8433999
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of expression of the CD45 tyrosine protein phosphatase on the tyrosine phosphorylation of the lck, fyn, and c-src tyrosine protein kinases.
Hurley TR; Hyman R; Sefton BM
Mol Cell Biol; 1993 Mar; 13(3):1651-6. PubMed ID: 8441403
[TBL] [Abstract][Full Text] [Related]
9. CD45 tyrosine phosphatase-activated p59fyn couples the T cell antigen receptor to pathways of diacylglycerol production, protein kinase C activation and calcium influx.
Shiroo M; Goff L; Biffen M; Shivnan E; Alexander D
EMBO J; 1992 Dec; 11(13):4887-97. PubMed ID: 1464315
[TBL] [Abstract][Full Text] [Related]
10. CD45 and RPTPalpha display different protein tyrosine phosphatase activities in T lymphocytes.
Ng DH; Jabali MD; Maiti A; Borodchak P; Harder KW; Brocker T; Malissen B; Jirik FR; Johnson P
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):867-76. PubMed ID: 9581568
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases.
Chuang E; Lee KM; Robbins MD; Duerr JM; Alegre ML; Hambor JE; Neveu MJ; Bluestone JA; Thompson CB
J Immunol; 1999 Feb; 162(3):1270-7. PubMed ID: 9973379
[TBL] [Abstract][Full Text] [Related]
12. Age-related impairments in TCR/CD3 activation of ZAP-70 are associated with reduced tyrosine phosphorylations of zeta-chains and p59fyn/p56lck in human T cells.
Whisler RL; Chen M; Liu B; Newhouse YG
Mech Ageing Dev; 1999 Nov; 111(1):49-66. PubMed ID: 10576607
[TBL] [Abstract][Full Text] [Related]
13. Residues Y429 and Y463 of the human CD5 are targeted by protein tyrosine kinases.
Vilà JM; Gimferrer I; Padilla O; Arman M; Places L; Simarro M; Vives J; Lozano F
Eur J Immunol; 2001 Apr; 31(4):1191-8. PubMed ID: 11298344
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD45 lacking the catalytic protein tyrosine phosphatase domain modulates Lck phosphorylation and T cell activation.
Wang Y; Johnson P
J Biol Chem; 2005 Apr; 280(14):14318-24. PubMed ID: 15687496
[TBL] [Abstract][Full Text] [Related]
15. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.
Burgess KE; Yamamoto M; Prasad KV; Rudd CE
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9311-5. PubMed ID: 1384049
[TBL] [Abstract][Full Text] [Related]
16. Treatment of human T cells with bisperoxovanadium phosphotyrosyl phosphatase inhibitors leads to activation of cyclooxygenase-2 gene.
Barat C; Tremblay MJ
J Biol Chem; 2003 Feb; 278(9):6992-7000. PubMed ID: 12493747
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases.
Livolsi A; Busuttil V; Imbert V; Abraham RT; Peyron JF
Eur J Biochem; 2001 Mar; 268(5):1508-15. PubMed ID: 11231305
[TBL] [Abstract][Full Text] [Related]
18. Expression and catalytic activities of protein tyrosine kinases (PTKs) Fyn and Lck in peripheral blood T cells from elderly humans stimulated through the T cell receptor (TCR)/CD3 complex.
Whisler RL; Bagenstose SE; Newhouse YG; Carle KW
Mech Ageing Dev; 1997 Oct; 98(1):57-73. PubMed ID: 9255758
[TBL] [Abstract][Full Text] [Related]
19. Interaction of CD4:lck with the T cell receptor/CD3 complex induces early signaling events in the absence of CD45 tyrosine phosphatase.
Deans JP; Kanner SB; Torres RM; Ledbetter JA
Eur J Immunol; 1992 Mar; 22(3):661-8. PubMed ID: 1532148
[TBL] [Abstract][Full Text] [Related]
20. Increase in the specific activity of p50csk in proliferating T cells correlates with decreased specific activity of p56lck and p59fyn and reduced phosphorylation of CD3 subunits.
Orchansky PL; Ng DH; Johnson P; Teh HS
Mol Immunol; 1996 Apr; 33(6):531-40. PubMed ID: 8700169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
